SCIENTIFIC BACKGROUND

APC, BMPR1A, MUTYH, POLD1, POLE, SMAD4,STK11

Category:

Scientific Background

Hereditary polyposis colorectal cancer syndrome is a type of inherited colorectal cancer that is characterised by the presence of polyps. Different types of conditions, such as Familial Adenomatous Polyposis (FAP), MUTYH-associated polyposis syndrome and others, can be associated with the presence of polyps. These conditions are caused by germline gene mutations. They result is the formation of foreign masses in the gastrointestinal tract, which can increase the risk of developing colorectal cancer in the future.

 

PreSENTIA hereditary Colorectal Polyposis panel tests for numerous germline mutations that could cause colorectal cancers in the future. Identifying germline mutations associated with cancer susceptibility empowers healthcare providers and patients, as it allows them to take better and more informed decisions.

 

Who is this test for?

You should get tested if you meet at least one of the criteria below:

You have a personal history of colorectal cancer

You have a personal or family history of colorectal polyps

You have a personal or family history of other types of cancer

You have been diagnosed with colorectal cancer at a young age (<50)

You have first-degree relatives who have been diagnosed with colorectal cancer at a young age (<50)

You have been diagnosed with multiple primary cancers

You have a first degree relative diagnosed with FAP

You have >10 cumulative colorectal adenomas or colorectal adenomas in combination with extracolonic features associated with FAP

 

How many genes are tested in this panel?

7 genes

 

How many hereditary cancer syndromes are associated with this panel?

5 Hereditary cancer syndromes are associated with this panel. These are:

Familial Adenomatous Polyposis / Attenuated Familial Adenomatous Polyposis (APC)

Juvenile Polyposis syndrome (SMAD4, BMPR1A)

• MUTYH-associated polyposis syndrome (MUTYH)

• Peutz-Jeghers syndrome (STK11)

• Polymerase proofreading associated syndrome (POLD1, POLE)

 

Recommendations by professional bodies

ESMO recommends that patients with multiple colorectal adenomas (>10) should be considered for germline genetic testing panel. (Stjepanovic et al., 2019).

 

References and more information: 

Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ. Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol. 2017 Oct;112(10):1509-1525. doi: 10.1038/ajg.2017.212. Epub 2017 Aug 8. PMID: 28786406.

Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmaña J, Martinelli E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019 Oct 1;30(10):1558-1571. doi: 10.1093/annonc/mdz233. PMID: 31378807.

GENES

APC, BMPR1A, MUTYH, POLD1, POLE, SMAD4,STK11
How to order

LATEST ARTICLES

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more